SE9902267D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9902267D0
SE9902267D0 SE9902267A SE9902267A SE9902267D0 SE 9902267 D0 SE9902267 D0 SE 9902267D0 SE 9902267 A SE9902267 A SE 9902267A SE 9902267 A SE9902267 A SE 9902267A SE 9902267 D0 SE9902267 D0 SE 9902267D0
Authority
SE
Sweden
Prior art keywords
new compounds
formula
pharmaceutically acceptable
treatment
acceptable salts
Prior art date
Application number
SE9902267A
Other languages
Swedish (sv)
Inventor
Yevgeni Besidski
Britt-Marie Swahn
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9902267A priority Critical patent/SE9902267D0/en
Publication of SE9902267D0 publication Critical patent/SE9902267D0/en
Priority to PCT/SE2000/001250 priority patent/WO2000076990A1/en
Priority to AU60321/00A priority patent/AU6032100A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Abstract

The present invention relates to certain aminoalkyl substituted heterocyclic compounds of formula (I), and pharmaceutically acceptable salts thereof, which exhibit good analgesic properties and are particularly effective in the treatment of chronic pain.
SE9902267A 1999-06-16 1999-06-16 New compounds SE9902267D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9902267A SE9902267D0 (en) 1999-06-16 1999-06-16 New compounds
PCT/SE2000/001250 WO2000076990A1 (en) 1999-06-16 2000-06-15 New compounds
AU60321/00A AU6032100A (en) 1999-06-16 2000-06-15 New compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9902267A SE9902267D0 (en) 1999-06-16 1999-06-16 New compounds

Publications (1)

Publication Number Publication Date
SE9902267D0 true SE9902267D0 (en) 1999-06-16

Family

ID=20416099

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9902267A SE9902267D0 (en) 1999-06-16 1999-06-16 New compounds

Country Status (3)

Country Link
AU (1) AU6032100A (en)
SE (1) SE9902267D0 (en)
WO (1) WO2000076990A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073269A2 (en) * 1999-06-02 2000-12-07 Regents Of The University Of Minnesota Nicotine receptor ligands
WO2003020728A1 (en) 2001-08-30 2003-03-13 Pharmacia & Upjohn Company 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS
EP1432696A1 (en) 2001-10-04 2004-06-30 Wyeth Chroman derivatives as 5-hydroxytryptamine-6 ligands
WO2003029239A1 (en) 2001-10-04 2003-04-10 Wyeth Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands
AR038294A1 (en) 2002-01-14 2005-01-12 Upjohn Co OXOTIENE (3,2-B) PYRIDINCARBOXAMIDS AS ANTIVIRAL AGENTS
AR038117A1 (en) 2002-01-14 2004-12-29 Upjohn Co ANTIVIRAL AGENTS DERIVED FROM 4- OXO-4,7 -DIHYDROFIDE [2,3-B] PIRIDIN-5-CARBOXAMIDA
AR038118A1 (en) 2002-01-14 2004-12-29 Upjohn Co COMPOUNDS DERIVED FROM ACID BENCINAMIDE 7-OXO-4,7-DIHIDROTIEN [2,3-B [PIRIDIN-6-CARBOXYLIC 3-REPLACED WHICH ARE USEFUL AS ANTIVIRAL
US7728155B2 (en) 2003-10-24 2010-06-01 Wyeth Llc Dihydrobenzofuranyl alkanamines and methods for using same as cns agents
EP1871356A1 (en) * 2005-04-22 2008-01-02 Wyeth a Corporation of the State of Delaware Dihydrobenzofuran derivatives and uses thereof
AU2006239917A1 (en) * 2005-04-22 2006-11-02 Wyeth (7-arlysubstituted 2, 3-dihydr0-1-benz0furan-2-yl) alkylamines in the treatment' of substance abuse
WO2006116149A1 (en) 2005-04-22 2006-11-02 Wyeth New therapeutic combianations for the treatment or prevention of depression
US20060258713A1 (en) * 2005-04-22 2006-11-16 Wyeth Treatment of pain
SG11201706515QA (en) * 2015-02-11 2017-09-28 Sunovion Pharmaceuticals Inc 1-heterocyclyl isochromanyl compounds and analogs for treating cns disorders
BR112021014754A2 (en) 2019-02-01 2021-09-28 Fmc Corporation COMPOUND, HERBICIDAL COMPOSITION, HERBICIDAL MIXTURE AND METHOD TO CONTROL THE GROWTH OF UNWANTED VEGETATION

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3513239A (en) * 1967-03-15 1970-05-19 Smithkline Corp Pharmaceutical compositions containing 2-aminoalkyl coumaran derivatives and methods of treating depression therewith
CH567011A5 (en) * 1972-12-19 1975-09-30 Eisai Co Ltd
NZ201219A (en) * 1981-07-28 1984-10-19 Reckitt & Colmann Prod Ltd Dihydrobenzofuranyl-2-imidazolines and pharmaceutical compositions
JPH077508B2 (en) * 1988-11-16 1995-01-30 株式会社東芝 Magnetic disk manufacturing method
GB9020128D0 (en) * 1990-09-14 1990-10-24 Reckitt & Colmann Prod Ltd Imidazoline derivatives
IE68675B1 (en) * 1990-11-01 1996-07-10 Takeda Chemical Industries Ltd Aminocoumaran derivatives their production and use
FR2761072B1 (en) * 1997-03-20 1999-04-23 Synthelabo 2,3-DIHYDROFURO [3,2-B] PYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Also Published As

Publication number Publication date
AU6032100A (en) 2001-01-02
WO2000076990A1 (en) 2000-12-21

Similar Documents

Publication Publication Date Title
IS8502A (en) Azate cyclic heterocycles as cannabinoid receptor antagonists
SE0101387D0 (en) Novel compounds
EP1426375A3 (en) Analgesic spiroindole derivatives
SE9900961D0 (en) Novel compounds
BR0109703A (en) Piperazine Derivatives
CY1107850T1 (en) THIADIAZYLOPIPERAZINE PRODUCT WITH USE IN APTROPIC OR IN ACTION AGAINST ALGUES
PT1147110E (en) PIRAZINE (AZA) -INDOL DERIVATIVES
DE60210944D1 (en) N-SUBSTITUTED HETEROCYCLIC NONARYL-NMDA / NR2B ANTAGONISTS
GEP20053600B (en) 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors
ATE360631T1 (en) AZABICYCLIC HETEROCYCLES AS MODULATORS OF THE CANNABINOID RECEPTOR
CY1106697T1 (en) N-SUBSTITUTED HYDROMORPHONES AND THEIR USE
ATE384058T1 (en) THIAZOLE DERIVATIVES
SE9902267D0 (en) New compounds
SE0402762D0 (en) Indazole sulphonamide derivatives
SE9802208D0 (en) Novel compounds
PE20030061A1 (en) 1-BIARIL-1,8-NAPHTHYRIDIN-4-ONA AS PHOSPHODIESTERASE-4 INHIBITORS
SE0302573D0 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
NO20043115L (en) Substituted diketopiperazines as oxytocin antagonists
SE0302570D0 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
EE200300129A (en) Use of distamycin alpha-haloacryloyl derivative
SE9802209D0 (en) Novel compounds
SE0302572D0 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
GEP201606538B (en) Preoperative treatment of post operative pain
ATE262362T1 (en) USE OF CYAMEMAZINE TO TREAT WITHDRAWING SYMPTOMS OF BENZODIAZEPINE TREATMENT
SE9802538D0 (en) New pharmaceutically active compounds